Literature DB >> 33782574

A combination of immunoadjuvant nanocomplexes and dendritic cell vaccines in the presence of immune checkpoint blockade for effective cancer immunotherapy.

Manh-Cuong Vo1,2,3, Seo-Yeon Ahn2,3, Tan-Huy Chu2, Saji Uthaman4, Shammer Pillarisetti5, Tung Nguyen Thanh Uong6, Thangaraj Jaya Lakshmi2, Mihee Kim3, Ga-Young Song3, Sung-Hoon Jung2,3, Deok-Hwan Yang3, Jae-Sook Ahn3, Hyeoung-Joon Kim3, In-Kyu Park7, Je-Jung Lee8,9.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33782574      PMCID: PMC8166870          DOI: 10.1038/s41423-021-00666-z

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   22.096


× No keyword cloud information.
  2 in total

Review 1.  Inborn Errors of Immunity and Cancer.

Authors:  Alessandra Tiri; Riccardo Masetti; Francesca Conti; Anna Tignanelli; Elena Turrini; Patrizia Bertolini; Susanna Esposito; Andrea Pession
Journal:  Biology (Basel)       Date:  2021-04-09

2.  AHCC®, a Standardized Extract of Cultured Lentinula Edodes Mycelia, Promotes the Anti-Tumor Effect of Dual Immune Checkpoint Blockade Effect in Murine Colon Cancer.

Authors:  Hong-Jai Park; Sunjin Boo; Inkeun Park; Min Sun Shin; Tsukasa Takahashi; Jun Takanari; Kohei Homma; Insoo Kang
Journal:  Front Immunol       Date:  2022-04-20       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.